
Cardiotoxin Analog (CTX) IV (6-12) TFA
CAS No. ——
Cardiotoxin Analog (CTX) IV (6-12) TFA ( —— )
产品货号. M29988 CAS No. ——
Cardiotoxin Analog (CTX) IV (6-12) (TFA) is a part peptide of Cardiotoxin Analog (CTX) IV. Cardiotoxin analogues IV isolated from the venom of Taiwan Cobra. CTX IV is an unique snake venom cardiotoxin.
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥958 | 有现货 |
![]() ![]() |
10MG | ¥1778 | 有现货 |
![]() ![]() |
25MG | ¥3010 | 有现货 |
![]() ![]() |
50MG | ¥4291 | 有现货 |
![]() ![]() |
100MG | ¥6214 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Cardiotoxin Analog (CTX) IV (6-12) TFA
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Cardiotoxin Analog (CTX) IV (6-12) (TFA) is a part peptide of Cardiotoxin Analog (CTX) IV. Cardiotoxin analogues IV isolated from the venom of Taiwan Cobra. CTX IV is an unique snake venom cardiotoxin.
-
产品描述Cardiotoxin Analog (CTX) IV (6-12) (TFA) is a part peptide of Cardiotoxin Analog (CTX) IV. Cardiotoxin analogues IV isolated from the venom of Taiwan Cobra. CTX IV is an unique snake venom cardiotoxin.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number——
-
分子量1013.16
-
分子式C50H71F3N10O9
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称Sequence:{Leu}{Ile}{Pro}{Pro}{Phe}{Trp}{Lys}-NH2
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
Kaneda N, et al. The amino acid sequence of cardiotoxin-analogue IV from the venom of Naja naja atra. FEBS Lett. 1976 Nov;70(1):217-22.
产品手册




关联产品
-
L-Propargylglycine
L-Propargylglycine 是酶的抑制剂。L-Propargylglycine (LPG) 以剂量和时间依赖性方式不可逆地抑制 Crotalus adamanteus 和 Crotalus atrox 的酶。失活是不可逆的,受到底物l-苯丙氨酸的显着保护。
-
Potassium 1-Naphthal...
1-萘乙酸酯用作植物生长调节剂,影响分生孢子萌发、孢子形成、菌丝生长、细胞表面形态和某些真菌植物病原体的活力。
-
Dermorphin Analog
Dermorphin Analog is an analog of Dermorphin. Dermorphin is a natural heptapeptide μ-opioid receptor agonist found in amphibian skin. The dermorphin-derived peptide [Dmt1] dermorphin analog labels m-opioid receptors with high affinity and selectivity in receptor binding assays.